Your browser doesn't support javascript.
loading
Implementation of a pathological diagnosis and treatment pathway may improve the molecular detection of lung cancer.
Shi, Chao; Wei, Bing; Liu, Xiaohui; Meng, Lin; Zhao, Chengzhi; Chang, Yuxi; Sun, Rui; Zhang, Zhongxian; Yu, Yang; Ma, Jie.
Affiliation
  • Shi C; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Wei B; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
  • Liu X; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Meng L; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
  • Zhao C; Novogene Co., Ltd., Beijing, China.
  • Chang Y; Novogene Co., Ltd., Beijing, China.
  • Sun R; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Zhang Z; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
  • Yu Y; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Ma J; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
Ann Transl Med ; 10(2): 45, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35282093
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Guideline Language: En Journal: Ann Transl Med Year: 2022 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Guideline Language: En Journal: Ann Transl Med Year: 2022 Document type: Article Affiliation country: China Country of publication: China